학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 23건 | 목록 1~10
Academic Journal
Dent RA; National Cancer Centre, Singapore, Singapore.; Kim SB; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea (South), Republic of.; Oliveira M; Vall d'Hebron Institute of Oncology, Barcelona, Barcelona, Spain.; Barrios C; Centro de Pesquisa em Oncologia, Hospital São Lucas, PUCRS Latin American Cooperative Oncology Group (LACOG), Porto Alegre, RS, Brazil.; O'Shaughnessy J; Sarah Cannon, United States.; Isakoff SJ; Massachusetts General Hospital, Boston, MA, United States.; Saji S; Fukushima Medical University, Fukushima, Fukushima, Japan.; Freitas-Junior R; Federal University of Goias, Goiania, Goias, Brazil.; Philco M; Instituto Peruano de Oncologia y Radioterapia, San Isidro, Peru.; Bondarenko I; Dnipro State Medical University, Dnipro, Ukraine.; Lian Q; Genentech, Inc., South San Francisco, United States.; Bradley D; Roche Products Ltd, Welwyn Garden City, United Kingdom.; Hinton H; Roche (Switzerland), Basel, Switzerland.; Wongchenko MJ; Genentech Inc., South San Francisco, United States.; Reilly SJ; Roche Products Ltd, Welwyn Garden City, United Kingdom.; Turner N; Royal Marsden NHS Foundation Trust, London, United Kingdom.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Taraborrelli L; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA.; Şenbabaoğlu Y; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA.; Wang L; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA.; Lim J; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA.; Blake K; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA.; Kljavin N; Department of Molecular Oncology, Genentech Inc., South San Francisco, USA.; Gierke S; Center for Advanced Light Microscopy, Genentech Inc., South San Francisco, USA.; Department of Pathology, Genentech Inc., South San Francisco, USA.; Scherl A; Department of Pathology, Genentech Inc., South San Francisco, USA.; Ziai J; Department of Pathology, Genentech Inc., South San Francisco, USA.; McNamara E; Department of In Vivo Pharmacology, Genentech Inc., South San Francisco, USA.; Owyong M; Department of In Vivo Pharmacology, Genentech Inc., South San Francisco, USA.; Rao S; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA.; Calviello AK; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA.; Oreper D; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA.; Jhunjhunwala S; Department of Oncology Bioinformatics, Genentech Inc., South San Francisco, USA.; Argiles G; Vall d'Hebrón Institute of Oncology, Vall d'Hebrón University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.; Bendell J; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.; Kim TW; Department of Oncology, Medical Center, University of Ulsan, Seoul, Korea.; Ciardiello F; Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy.; Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.; de Sauvage FJ; Department of Molecular Oncology, Genentech Inc., South San Francisco, USA.; de Sousa E Melo F; Department of Discovery Oncology, Genentech Inc., South San Francisco, USA.; Yan Y; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.; West NR; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA. west.nathaniel@gene.com.; Murthy A; Department of Cancer Immunology, Genentech Inc., South San Francisco, USA. aditya.murthy@gilead.com.; Gilead Sciences, Foster City, USA. aditya.murthy@gilead.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Shi Z; Department of Oncology Biomarker, Genentech Inc., South San Francisco, California.; Wulfkuhle J; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.; Nowicka M; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Gallagher RI; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.; Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Nuciforo PG; Molecular Oncology Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Calvo I; Breast Cancer Unit, Centro Integral Oncologico Clara Campal (CIOCC), Madrid, Spain.; Andersen J; Medical Oncology/Hematology, Compass Oncology, Tigard, Oregon.; Passos-Coelho JL; Oncology Department, Hospital Beatriz Angelo, Loures, Portugal.; Gil-Gil MJ; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Medical Oncology Service, Institut Català d'Oncologia, L'Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Barcelona, Spain.; Bermejo B; Hospital Clinico Universitario de Valencia, Valencia, Spain.; Pratt DA; Texas Oncology Cancer Center, US Oncology, Austin, Texas.; Ciruelos EM; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Medical Oncology Department, University Hospital 12 de Octubre, Madrid, Spain.; Villagrasa P; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Wongchenko MJ; Department of Oncology Biomarker, Genentech Inc., South San Francisco, California.; Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia.; Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain.; Isakoff SJ; Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Turner N; Breast Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ, UK. Nick.Turner@icr.ac.uk.; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK. Nick.Turner@icr.ac.uk.; Dent RA; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.; O'Shaughnessy J; Department of Medical Oncology, Texas Oncology, Baylor University Medical Center, US Oncology, Dallas, TX, USA.; Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Isakoff SJ; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA.; Barrios C; Latin American Cooperative Oncology Group, Oncology Research Service, Hospital São Lucas, PUCRS, Porto Alegre, RS, Brazil.; Saji S; Department of Medical Oncology, Fukushima Medical University Hospital, Fukushima, Japan.; Bondarenko I; Oncology and Medical Radiology Department, City Clinical Hospital No. 4, Dnipropetrovsk, Ukraine.; Nowecki Z; Oncology Centre, Instytut im. Marii-Sklodowskiej, Warsaw, Poland.; Lian Q; Biostatistics, Genentech, Inc, South San Francisco, CA, USA.; Reilly SJ; Pharma Development, Roche Products Ltd, Welwyn Garden City, UK.; Hinton H; Product Development Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc, South San Francisco, CA, USA.; Kovic B; Patient-Centered Outcomes Research, Product Development, Hoffmann-La Roche Limited, Mississauga, ON, Canada.; Mani A; Product Development Oncology, Genentech, Inc, South San Francisco, CA, USA.; Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Dent R; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore. rebecca.dent@duke-nus.edu.sg.; Duke-NUS Medical School, 11 Hospital Crescent, Singapore, Singapore. rebecca.dent@duke-nus.edu.sg.; Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Isakoff SJ; Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, USA.; Im SA; Department of Internal Medicine, Seoul National University Hospital, and Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.; Espié M; Department of Medical Oncology, Breast Disease Center, Hospital Saint Louis, Paris, France.; Blau S; Oncology Division, Northwest Medical Specialties, Puyallup, WA, USA.; Tan AR; Department of Solid Tumor and Investigational Therapeutics, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.; Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc., South San Francisco, CA, USA.; Xu N; Biostatistics, Genentech, Inc., South San Francisco, CA, USA.; Bradley D; Pharma Development, Roche Products Ltd, Welwyn Garden City, UK.; Reilly SJ; Pharma Development, Roche Products Ltd, Welwyn Garden City, UK.; Mani A; Product Development Oncology, Genentech, Inc., South San Francisco, CA, USA.; Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Academic Journal
Sweeney C; Dana-Farber Cancer Institute, Boston, MA, USA.; Bracarda S; Azienda Ospedaliera Santa Maria, Terni, Italy.; Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York-Presbyterian, New York City, NY, USA.; Chi KN; BC Cancer, Vancouver, BC, Canada.; Olmos D; Spanish National Cancer Research Centre (CNIO), Madrid, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.; Sandhu S; Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.; Massard C; Institut Gustave Roussy, Villejuif, France.; Matsubara N; National Cancer Center Hospital East, Chiba, Japan.; Alekseev B; P A Herzen Moscow Oncology Research Institute, Moscow, Russia.; Parnis F; Ashford Cancer Centre Research, Kurralta Park, SA, Australia.; Atduev V; Volga District Medical Centre under Federal Medical and Biological Agency of Russia, Nizhny Novgorod, Russia.; Buchschacher GL Jr; Kaiser Permanente Southern California, Los Angeles Medical Center, Los Angeles, CA, USA.; Gafanov R; Russian Scientific Center of Roentgenology and Radiology, Moscow, Russia.; Corrales L; Medical Oncology, Centro de Investigación y Manejo del Cáncer CIMCA, San José, Costa Rica.; Borre M; Aarhus University Hospital, Aarhus, Denmark.; Stroyakovskiy D; Moscow City Oncology Hospital Number 62 of Moscow Healthcare Department, Moscow Oblast, Russia.; Alves GV; Centro Integrado de Pesquisa em Oncologia, Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.; Bournakis E; Oncologic Clinical Trials and Research Clinic, Metropolitan General Hospital, Athens, Greece.; Puente J; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain.; Harle-Yge ML; F Hoffmann-La Roche, Basel, Switzerland.; Gallo J; F Hoffmann-La Roche, Basel, Switzerland.; Chen G; Genentech, South San Francisco, CA, USA.; Hanover J; Genentech, South San Francisco, CA, USA.; Wongchenko MJ; Genentech, South San Francisco, CA, USA.; Garcia J; F Hoffmann-La Roche, Basel, Switzerland.; de Bono JS; Division of Clinical Studies, The Institute of Cancer Research, London, UK; Drug Development Unit, Royal Marsden Hospital, Sutton, UK. Electronic address: johann.de-bono@icr.ac.uk.
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE
Academic Journal
Daemen A; Department of Bioinformatics & Computational Biology, Genentech, Inc., South San Francisco, California. anneleen.daemen@oricpharma.com melissa.junttila@oricpharma.com.; Cooper JE; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California.; Myrta S; Roche Global IT Solution Centre, Roche, Warsaw, Poland.; Wongchenko MJ; Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.; Lin E; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California.; Long JE; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California.; Foreman O; Department of Research Pathology, Genentech, Inc., South San Francisco, California.; Modrusan Z; Department of Microchemistry, Proteomics and Lipidomics, Genentech, Inc., South San Francisco, California.; Tremayne JR; Department of Translational Oncology, Genentech, Inc., South San Francisco, California.; de la Cruz CC; Department of Translational Oncology, Genentech, Inc., South San Francisco, California.; Merchant M; Department of Translational Oncology, Genentech, Inc., South San Francisco, California.; Martin SE; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California.; Yan Y; Department of Oncology Biomarker Development, Genentech, Inc., South San Francisco, California.; Junttila MR; Department of Molecular Oncology, Genentech, Inc., South San Francisco, California. anneleen.daemen@oricpharma.com melissa.junttila@oricpharma.com.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Wongchenko MJ; Oncology Biomarker Development, Genentech, South San Francisco, CA.; Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.; Saura C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Lipson D; Foundation Medicine, Cambridge, MA.; Kennedy M; Foundation Medicine, Cambridge, MA.; Greene M; Foundation Medicine, Cambridge, MA.; Breese V; Foundation Medicine, Cambridge, MA.; Mani A; Product Development, Genentech, South San Francisco, CA.; Xu N; Product Development Biostatistics, Genentech, South San Francisco, CA.; Dent R; Division of Medical Oncology, National Cancer Centre, Singapore, Singapore.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Shapiro GI; Dana-Farber Cancer Institute, Mayer 446, 450 Brookline Avenue, Boston, MA, 02215, USA. geoffrey_shapiro@dfci.harvard.edu.; LoRusso P; Yale Cancer Center, New Haven, CT, USA.; Kwak E; Massachusetts General Hospital Cancer Center, Boston, MA, USA.; Pandya S; Beth Israel Deaconess Medical Center, Boston, MA, USA.; Rudin CM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Kurkjian C; Stephenson Cancer Center University of Oklahoma, Oklahoma City, OK, USA.; Cleary JM; Dana-Farber Cancer Institute, Mayer 446, 450 Brookline Avenue, Boston, MA, 02215, USA.; Pilat MJ; Wayne State University, Detroit, MI, USA.; Jones S; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.; de Crespigny A; Genentech, Inc., South San Francisco, CA, USA.; Fredrickson J; Genentech, Inc., South San Francisco, CA, USA.; Musib L; Genentech, Inc., South San Francisco, CA, USA.; Yan Y; Genentech, Inc., South San Francisco, CA, USA.; Wongchenko M; Genentech, Inc., South San Francisco, CA, USA.; Hsieh HJ; Genentech, Inc., South San Francisco, CA, USA.; Gates MR; Genentech, Inc., South San Francisco, CA, USA.; Chan IT; Genentech, Inc., South San Francisco, CA, USA.; Bendell J; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE
Academic Journal
Ascierto PA; Melanoma Unit, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy. Electronic address: p.ascierto@istitutotumori.na.it.; Lewis KD; Department of Medicine, University of Colorado Comprehensive Cancer Center, Aurora, Colorado, USA.; Di Giacomo AM; Division of Medical Oncology and Immunotherapy, University Hospital of Siena, Siena, Italy.; Demidov L; Department of Biotherapy, N. N. Blokhin Russian Cancer Research Center, Ministry of Health, Moscow, Russia.; Mandalà M; Department of Oncology and Haematology, Papa Giovanni XXIII Cancer Center Hospital, Bergamo, Italy.; Bondarenko I; Dnipropetrovsk State Medical Academy, Dnipropetrovsk, Ukraine.; Herbert C; Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.; Mackiewicz A; Department of Cancer Immunology, Poznan University of Medical Sciences, Med-POLONIA, Poznan, Poland.; Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland.; Guminski A; Melanoma Translational Research Group, Melanoma Institute Australia, Wollstonecraft, New South Wales, Australia.; Simmons B; Product Development Oncology, Genentech, Inc., South San Francisco, California, USA.; Ye C; Oncology Biostatistics, Genentech, Inc., South San Francisco, California, USA.; Hooper G; Clinical Development Department, Roche Products Ltd., Welwyn Garden City, UK.; Wongchenko MJ; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California, USA.; Goodman GR; Safety Science Oncology, Genentech, Inc., South San Francisco, California, USA.; Yan Y; Oncology Biomarker Development, Genentech, Inc., South San Francisco, California, USA.; Schadendorf D; Department of Dermatology, Essen University Hospital, Essen, Germany; German Cancer Consortium, Heidelberg, Germany.
Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[Author] Wongchenko MJ
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어